Anthem, Inc. (NYSE:ANTM) Expected to Post Earnings of $6.30 Per Share

Analysts expect Anthem, Inc. (NYSE:ANTM) to report $6.30 earnings per share for the current quarter, Zacks reports. Four analysts have provided estimates for Anthem’s earnings, with the highest EPS estimate coming in at $6.55 and the lowest estimate coming in at $6.04. Anthem reported earnings per share of $9.20 in the same quarter last year, which suggests a negative year over year growth rate of 31.5%. The business is scheduled to issue its next quarterly earnings report on Wednesday, August 4th.

On average, analysts expect that Anthem will report full year earnings of $25.09 per share for the current financial year, with EPS estimates ranging from $24.67 to $25.38. For the next financial year, analysts forecast that the company will report earnings of $28.16 per share, with EPS estimates ranging from $25.87 to $29.00. Zacks’ EPS calculations are an average based on a survey of research firms that follow Anthem.

Anthem (NYSE:ANTM) last issued its quarterly earnings results on Tuesday, April 20th. The company reported $7.01 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $6.86 by $0.15. Anthem had a return on equity of 18.45% and a net margin of 4.22%. The firm had revenue of $32.10 billion during the quarter, compared to analysts’ expectations of $32.98 billion. During the same period in the previous year, the business earned $6.48 earnings per share. The firm’s revenue for the quarter was up 9.0% on a year-over-year basis.

A number of analysts have commented on the stock. Barclays increased their price objective on shares of Anthem from $375.00 to $425.00 and gave the company an “overweight” rating in a report on Wednesday, April 28th. Cowen upped their target price on Anthem from $360.00 to $395.00 and gave the company an “outperform” rating in a report on Tuesday, April 20th. Credit Suisse Group lifted their price target on Anthem from $382.00 to $425.00 and gave the stock an “outperform” rating in a report on Wednesday, April 28th. Stephens raised their price objective on shares of Anthem from $395.00 to $430.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 28th. Finally, Zacks Investment Research lowered shares of Anthem from a “hold” rating to a “sell” rating and set a $379.00 target price on the stock. in a report on Thursday, March 25th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and fifteen have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus price target of $393.65.

Shares of NYSE ANTM traded down $1.52 during mid-day trading on Tuesday, reaching $393.93. The company’s stock had a trading volume of 677,314 shares, compared to its average volume of 1,271,697. The stock has a market capitalization of $96.45 billion, a P/E ratio of 20.37, a P/E/G ratio of 0.92 and a beta of 1.00. Anthem has a 1-year low of $244.10 and a 1-year high of $406.00. The stock has a 50-day moving average of $374.29 and a two-hundred day moving average of $329.77. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.59 and a current ratio of 1.59.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 25th. Investors of record on Thursday, June 10th will be issued a $1.13 dividend. This represents a $4.52 annualized dividend and a dividend yield of 1.15%. The ex-dividend date is Wednesday, June 9th. This is an increase from Anthem’s previous quarterly dividend of $0.95. Anthem’s payout ratio is currently 23.25%.

In related news, CAO Ronald W. Penczek sold 2,068 shares of the company’s stock in a transaction that occurred on Friday, March 5th. The shares were sold at an average price of $333.94, for a total transaction of $690,587.92. Following the sale, the chief accounting officer now directly owns 3,137 shares of the company’s stock, valued at approximately $1,047,569.78. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Peter D. Haytaian sold 59,500 shares of the stock in a transaction that occurred on Monday, March 22nd. The stock was sold at an average price of $349.20, for a total transaction of $20,777,400.00. Following the sale, the executive vice president now owns 59,544 shares in the company, valued at $20,792,764.80. The disclosure for this sale can be found here. Company insiders own 0.22% of the company’s stock.

A number of hedge funds and other institutional investors have recently modified their holdings of ANTM. Ontario Teachers Pension Plan Board boosted its stake in shares of Anthem by 14.5% in the 1st quarter. Ontario Teachers Pension Plan Board now owns 4,020 shares of the company’s stock valued at $1,443,000 after buying an additional 509 shares during the period. Brown Advisory Inc. raised its holdings in Anthem by 3.7% in the first quarter. Brown Advisory Inc. now owns 424,926 shares of the company’s stock valued at $152,528,000 after acquiring an additional 15,214 shares in the last quarter. Citizens Financial Group Inc RI lifted its stake in Anthem by 29.8% in the first quarter. Citizens Financial Group Inc RI now owns 1,223 shares of the company’s stock worth $439,000 after acquiring an additional 281 shares during the last quarter. MML Investors Services LLC grew its holdings in Anthem by 7.2% during the 1st quarter. MML Investors Services LLC now owns 23,624 shares of the company’s stock worth $8,480,000 after acquiring an additional 1,587 shares in the last quarter. Finally, Lowe Brockenbrough & Co. Inc. raised its holdings in shares of Anthem by 2.3% in the 1st quarter. Lowe Brockenbrough & Co. Inc. now owns 37,452 shares of the company’s stock valued at $13,443,000 after purchasing an additional 839 shares in the last quarter. Institutional investors own 89.36% of the company’s stock.

About Anthem

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through four segments: Commercial & Specialty Business, Government Business, IngenioRx, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small groups, individuals, Medicaid, and Medicare markets.

Featured Article: Profit margin is different from the revenue

Get a free copy of the Zacks research report on Anthem (ANTM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Anthem (NYSE:ANTM)

Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.